Welcome Guest
Home > Clinical Genitourinary Cancer > Volume 5 | Supplement 1

Table of Contents

Volume 5 | Supplement 1

Publication Date: December 2006
  • Abstract Abstract
  • Full Text No Access
  • Full Text Pay-Per View
  • Full Text Full Text
  • Add to Cart Add to Cart


Introduction
Page Number of this Article in the Print Version
S6		 Renal Cell Carcinoma: Development of a New Treatment Paradigm
Ronald M. Bukowski
  • Abstract
  • No Access
  • Add to Cart
Contributions
Page Number of this Article in the Print Version
S7-S18		 Pathways of Dysregulation in Renal Cell Carcinoma: Rational Approaches to Development of Novel Treatment
Mohamad K. Khasawneh, Ronald M. Bukowski
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
S19-S23		 Tyrosine Kinase Inhibitors Compared with Cytokine Therapy for Metastatic Renal Cell Carcinoma: Overview of Recent Clinical Trials Differentiating Clinical Response and Adverse Effects
Robert Dreicer
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
S24-S30		 Improving Outcomes with Novel Therapies for Patients with Newly Diagnosed Renal Cell Carcinoma
JoEllen Speca, Sarah Yenser, Patricia Creel, Daniel George
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
S31-S39		 Targeting Growth Factor and Antiangiogenic Pathways in Clear-Cell Renal Cell Carcinoma: Rationale and Ongoing Trials
Thomas E. Hutson, Guru Sonpavde, Matthew D. Galsky
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
S40-S44		 Therapeutic Considerations in Patients with Metastatic Renal Cell Carcinoma Previously Treated with Antiangiogenic Therapies
Saby George, Brian I. Rini
  • Abstract
  • No Access
  • Add to Cart